Kisspeptin is a regulatory peptide hormone that plays a central role in the human reproductive system. It acts as a key upstream signal controlling hormonal cascades responsible for puberty onset, menstrual cycle regulation, fertility, and pregnancy. The peptide is encoded by the KISS1 gene and exists in several molecular forms, ranging from longer polypeptides (such as kisspeptin-54) to shorter active fragments.
The biological activity of kisspeptin is mediated through its binding to the KISS1 receptor (KISS1R). This interaction activates G-protein signaling pathways, leading to an increase in intracellular calcium levels and triggering downstream cascades including PLC, IP3, and DAG. As a result, protein kinase pathways such as PKC and ERK are activated, ultimately stimulating the secretion of gonadotropin-releasing hormone (GnRH).
KISS1R receptors are primarily expressed in the hypothalamus, particularly in the arcuate and preoptic nuclei, as well as in peripheral tissues including the ovaries and placenta. In addition to endocrine regulation, kisspeptin signaling has been associated with anti-metastatic activity through the modulation of apoptosis in certain tumor cells.
Kisspeptin is a critical trigger for the initiation of puberty. Genetic mutations affecting KISS1 or KISS1R can disrupt this signaling pathway, leading to hypogonadotropic hypogonadism, delayed sexual development, and infertility.
The activity of kisspeptin fluctuates throughout the menstrual cycle. It shows a positive correlation with estrogen (estradiol) levels, reaching peak activity prior to ovulation and contributing to the luteinizing hormone (LH) surge. In contrast, progesterone and neuropeptides such as dynorphin exert inhibitory effects during the luteal phase, reducing kisspeptin signaling.
Within the ovaries, kisspeptin is involved in follicular development and oocyte maturation. It also plays a role in endometrial receptivity and proper embryo implantation. Additionally, kisspeptin is associated with mechanisms that help reduce the risk of ectopic pregnancy.
Beyond reproductive physiology, kisspeptin contributes to broader metabolic regulation. Its signaling pathways intersect with mechanisms controlling energy balance, insulin sensitivity, and body composition. Variations in kisspeptin activity have been linked to metabolic disorders, including obesity, type 2 diabetes, and cardiovascular conditions.
Modern medicine increasingly emphasizes individualized care based on detailed patient profiling. At Refresh Clinic in Dubai, peptide-based and гормонально-метаболические protocols are tailored according to each patient’s metabolic and endocrine characteristics.
This personalized strategy allows for more precise correction of hormonal imbalances, optimization of reproductive health, and reduction of long-term risks associated with chronic conditions. By integrating diagnostic data with targeted interventions, clinicians aim to improve overall physiological resilience and quality of life.
Kisspeptin is a central regulator of reproductive and hormonal function, linking neuroendocrine signaling with fertility and metabolic health. Its role extends beyond puberty and the menstrual cycle, influencing systemic processes that are critical for long-term well-being. Understanding its mechanisms provides new opportunities for targeted and personalized therapeutic strategies.
